Generally, studies suggesting IFN-I suppression of T cell activation or enhancement of inflammatory chemokines/cytokines used Ifnar1-/- mice or multiple injections of anti-IFNAR antibodies, which are different from infections having a short time increase in IFN-I level. This evidence concerns the gene IFNAR1 and infection.